Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24004

1.

Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial.

Hobbs AJ, Moyes AJ, Baliga RS, Ghedia D, Ochiel R, Sylvestre Y, Doré CJ, Chowdhury K, Maclagan K, Quartly HL, Sofat R, Smit A, Schreiber BE, Coghlan JG, MacAllister RJ.

Br J Pharmacol. 2019 Feb 13. doi: 10.1111/bph.14621. [Epub ahead of print]

PMID:
30761523
2.

Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.

Qiu J, Li Q, Bell KA, Yao X, Du Y, Zhang E, Yu JJ, Yu Y, Shi Z, Jiang J.

Br J Pharmacol. 2019 Feb 14. doi: 10.1111/bph.14622. [Epub ahead of print]

PMID:
30761522
3.

β-adrenoceptor activation impacts galectin-3 as a biomarker and therapeutic target in heart disease.

Du XJ, Zhao WB, Nguyen MN, Lu Q, Kiriazis H.

Br J Pharmacol. 2019 Feb 12. doi: 10.1111/bph.14620. [Epub ahead of print] Review.

PMID:
30756388
4.

Histamine in the kidneys: What is its role in renal pathophysiology?

Grange C, Gurrieri M, Verta R, Fantozzi R, Pini A, Rosa AC.

Br J Pharmacol. 2019 Feb 11. doi: 10.1111/bph.14619. [Epub ahead of print] Review.

PMID:
30741418
5.

Adrenoceptor regulation of mTOR in muscle and adipose tissue.

Chia LY, Evans BA, Mukaida S, Bengtsson T, Hutchinson DS, Sato M.

Br J Pharmacol. 2019 Feb 10. doi: 10.1111/bph.14616. [Epub ahead of print] Review.

PMID:
30740664
6.

Updates in the Function and Regulation of α1 -Adrenoceptors.

Akinaga J, García-Sáinz JA, Pupo AS.

Br J Pharmacol. 2019 Feb 10. doi: 10.1111/bph.14617. [Epub ahead of print] Review.

PMID:
30740663
7.

Microglial inflammation and phagocytosis in Alzheimer's disease: potential therapeutic targets.

Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E.

Br J Pharmacol. 2019 Feb 10. doi: 10.1111/bph.14618. [Epub ahead of print] Review.

PMID:
30740661
8.

The impact of dihydropyridine derivatives on the cerebral blood flow response to somatosensory stimulation and spreading depolarization.

Szabó Í, Tóth OM, Török Z, Varga DP, Menyhárt Á, Frank R, Hantosi D, Hunya Á, Bari F, Horváth I, Vigh L, Farkas E.

Br J Pharmacol. 2019 Feb 9. doi: 10.1111/bph.14611. [Epub ahead of print]

PMID:
30737967
9.

An osteoclastogenesis system, the RANKL/RANK signaling pathway contributes to aggravated allergic inflammation.

Nam SY, Kim HY, Min JY, Kim HM, Jeong HJ.

Br J Pharmacol. 2019 Feb 9. doi: 10.1111/bph.14615. [Epub ahead of print]

PMID:
30737962
10.

Semaphorin 3E attenuates intestinal inflammation through the regulation of the communication between splenic CD11C+ and CD4+ CD25- T cells.

Kermarrec L, Eissa N, Wang H, Kapoor K, Diarra A, Gounni AS, Bernstein CN, Ghia JE.

Br J Pharmacol. 2019 Feb 8. doi: 10.1111/bph.14614. [Epub ahead of print]

PMID:
30736100
11.

Cannabinoids differentially modulate the cortical information transmission through the sensorimotor or medial prefrontal basal ganglia circuits.

Antonazzo M, Gutierrez-Ceballos A, Bustinza I, Ugedo L, Morera-Herreras T.

Br J Pharmacol. 2019 Feb 8. doi: 10.1111/bph.14613. [Epub ahead of print]

PMID:
30735570
12.

GSK2646264, a spleen tyrosine kinase inhibitor attenuates the release of histamine in ex vivo human skin.

Dickson M, Ramirez-Molina C, Falkencrone S, Skov PS, Hooper-Greenhill E, Barker M.

Br J Pharmacol. 2019 Feb 8. doi: 10.1111/bph.14610. [Epub ahead of print]

PMID:
30735243
13.

Pathology of white matter integrity in three major white matter fasciculi: A postmortem study of schizophrenia and treatment status.

Schoonover KE, Farmer CB, Cash AE, Roberts RC.

Br J Pharmacol. 2019 Feb 8. doi: 10.1111/bph.14612. [Epub ahead of print]

PMID:
30735241
14.

Hydrogen Sulfide Regulates Muscle RING Finger-1 Protein S-Sulfhydration at Cys44 to Prevent Cardiac Structural Damage in Diabetic Cardiomyopathy.

Sun X, Zhao D, Lu F, Peng S, Yu M, Liu N, Sun Y, Du H, Wang B, Chen J, Dong S, Lu F, Zhang W.

Br J Pharmacol. 2019 Feb 7. doi: 10.1111/bph.14601. [Epub ahead of print]

PMID:
30734268
15.

Vasoactive Intestinal Peptide shapes first trimester placenta trophoblast, vascular and immune cell cooperation.

Paparini DE, Choudhury RH, Vota DM, Karolczak-Bayatti M, Finn-Sell S, Grasso EN, Hauk VC, Ramhorst R, Pérez Leirós C, Aplin JD.

Br J Pharmacol. 2019 Feb 6. doi: 10.1111/bph.14609. [Epub ahead of print]

PMID:
30726565
16.

WHAT MAKES THE α1A -ADRENOCEPTOR GENE PRODUCT ASSUME A α1L -ADRENOCEPTOR PHENOTYPE?

White CW, da Silva Junior ED, Lim L, Ventura S.

Br J Pharmacol. 2019 Feb 4. doi: 10.1111/bph.14599. [Epub ahead of print] Review.

PMID:
30719698
17.

Cav3.2 calcium channel inhibition: a new target for colonic hypersensitivity associated with low-grade inflammation.

Picard E, Carvalho FA, Agosti F, Bourinet E, Ardid D, Eschalier A, Daulhac L, Mallet C.

Br J Pharmacol. 2019 Feb 4. doi: 10.1111/bph.14608. [Epub ahead of print]

PMID:
30714145
18.

Function of cyclic AMP scaffolds in obstructive lung disease: Focus on epithelial-to-mesenchymal transition and oxidative stress.

Zuo H, Cattani-Cavalieri I, Valença SS, Musheshe N, Schmidt M.

Br J Pharmacol. 2019 Feb 4. doi: 10.1111/bph.14605. [Epub ahead of print] Review.

PMID:
30714124
19.

Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Barus R, Béné J, Deguil J, Gautier S, Bordet R.

Br J Pharmacol. 2019 Feb 4. doi: 10.1111/bph.14607. [Epub ahead of print] Review.

PMID:
30714122
20.

The histidine decarboxylase model of tic pathophysiology: A new focus on the H3R receptor.

Pittenger C.

Br J Pharmacol. 2019 Feb 4. doi: 10.1111/bph.14606. [Epub ahead of print] Review.

PMID:
30714121

Supplemental Content

Loading ...
Support Center